ArticleEuropean heart journal. Digital health2026
Multi-horizon machine learning for population-level hypertension risk stratification in the UK Biobank.
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Hypertension is a major contributor to cardiovascular morbidity and mortality, yet identifying individuals at risk before clinical diagnosis remains challenging. Here, we present a multi-horizon machine learning framework designed to model incident hypertension risk across multiple clinically meaningful time windows using data from 246 286 participants in the UK Biobank. The framework systematically compares predictive performance across five horizons under severe class imbalance, enabling analysis of how discrimination, precision, and risk drivers evolve as outcome prevalence changes over time. Methods and results: Seven classification algorithms were evaluated, including logistic regression, random forest, naïve Bayes, and four boosting-based ensemble methods. To enhance interpretability, we integrate SHapley Additive exPlanations (SHAP) with generative topographic mapping (GTM), combining feature-level attribution with population-level visualization of model predictions. Ensemble boosting models consistently achieved the strongest performance, with average precision increasing from 0.04 for the ≤2-year horizon to 0.22 for the ≤10-year horizon, while ROC-AUC remained relatively stable (∼0.75-0.79). Together, this framework reveals consistent predictors of hypertension risk (including baseline blood pressure, age, body mass index, medication burden, and cardiometabolic multimorbidity) and illustrates how combinations of risk factors organize hypertension risk across time horizons. Conclusions: Our results demonstrate how multi-horizon modelling and complementary explainability approaches can provide deeper insight into evolving disease risk patterns in large biomedical cohorts, supporting more interpretable and scalable strategies for population-level cardiovascular prevention. Such approaches may enable earlier identification of high-risk individuals and inform targeted screening and preventive interventions in routine care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.